AzTrials
AzTrials

Kidney Transplant DonorNCT07793877

Modifiable Factors Affecting Racial Disparities in Kidney Donation

An observational study of Kidney Transplant Donor, run by The Methodist Hospital Research Institute.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

While many people offer to be evaluated at transplant centers as potential living donors to donate one kidney to someone they know, few ultimately donate. Racial/ethnic minorities are less likely to become living donors. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Kidney Transplant Donor
What is being tested?
Not applicable- observational study
How many people
2,332 participants
Where
No sites listed yet
Study dates
4 Feb 2022to 30 Nov 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: "Donor volunteers" defined as persons who contacted SBMC or UCLA to request an information packet regarding live kidney donation and then completed and returned a Living Donor Referral Form (included in the packet). Persons who received an information packet but failed to return the Living Donor Referral Form were not considered donor volunteers and were not eligible for the cohort study.

Who may be able to join

  • Live kidney donor volunteer

Who cannot join

  • Limited proficiency in both English and Spanish
  • Required assistance to fill out the study questionnaire
  • Non-directed donors (altruistic donors who lack a specific intended recipient)
  • Failure to complete baseline questionnaire

About this study

Official title: Modifiable Factors Affecting Live Donor Disparities (MFALDD) - Living Donors Secondary Analysis

While many people offer to be evaluated at transplant centers as potential living donors to donate one kidney to someone they know, few ultimately donate. Racial/ethnic minorities are less likely to become living donors. This study examines potentially modifiable factors affecting living donation in a large cohort of potential living donors from different transplant centers who are White, Black, Hispanic, and Asian. Investigators are examining ways to intervene with potential living donors to help overcome racial disparities and increase the number of people who ultimately donate.

Read the detailed description

The donor data collected for use in this protocol was completed from 2014 to 2018 at an outside institution. 2332 donor volunteers were evaluated at that time and all data was deidentified and brought by the principal investigator to HMRI for secondary data analysis. Five study aims were highlighted in the research strategy.

The first three aims in the original research strategy/protocol WILL NOT be included in this study because this study covers the secondary data analysis ONLY. The emphasis of this study are the last two aims (#4 and #5 of the original research strategy/protocol).

Being tested
Not applicable- observational study

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Not applicable- observational studyOther

    Potential living donors who presented for evaluation at 5 transplant centers were invited to participate in an exploratory study assessing their motivations for donating, their living donation knowledge, their financial barriers to donating, and their educational preparedness. All potential living donors completed Survey 1, and a subset of individuals who completed living donor evaluation, completed Survey 2. After 12 months, chart review for all individuals who completed Survey 1 occurred to determine whether they received a transplant or not, and if not what reasons they were ruled out. No data collection took place at Houston Methodist.

Study groups in NCT07793877
Study groupRoleWhat they receive
Living Donor VolunteersIndividuals interested in donating a live kidney
Receives: Other: Not applicable- observational study

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. How Changeable Factors Affect Completion of Living Donor Evaluation for Black, Hispanic, and White Volunteers

    Metrics of interest include whether donor volunteers present for evaluation, defined as attending the first in-person visit, and whether they complete the donor evaluation, defined as finishing all required steps except donation. Both outcomes are measured as yes or no. Investigators will use logistic regression to examine differences in the likelihood of presentation and completion among Black, Hispanic, and White donors. Initial analyses will examine the relationship between race and each outcome separately. Race will then be included in multivariable models, with survey-based factors added by category. Changes in the size or significance of race effects after adjustment will be evaluated. If the association between race and evaluation outcomes is reduced after accounting for specific modifiable factors, these factors may represent potential targets for future interventions.

    Measured: From onset of evaluation to the outcomes at 12 months

Secondary outcomes (1)
  1. How Changeable Factors Influence Whether Living Donors Go on to Donate, Including Through Paired Exchange

    Investigators will compare the odds of donating a kidney directly or through paired exchange among Black, Hispanic, and White donor volunteers using logistic regression models. Model fit will be assessed as previously described. As in the primary measure, the bivariate relationship between donor race and each outcome will first be examined using simple logistic regression. Race will then be forced into successive models, with survey variables entered simultaneously by category. Investigators will track whether the magnitude (odds ratio) or significance of the race effect changes as additional factors are included.

    Measured: From the onset of evaluation until the date of first documented live kidney donation, assessed up to 18 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Aug 2026
  2. Study start4 Feb 2022
  3. Primary completion30 Nov 2025
  4. Study completion30 Nov 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
2,332 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07793877
Sponsor's protocol ID
PRO00033546
Status last verified
May 2026
First submitted
27 May 2026
Last updated
31 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Kidney Transplant Donor, run by The Methodist Hospital Research Institute.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

How Changeable Factors Affect Completion of Living Donor Evaluation for Black, Hispanic, and White Volunteers (time frame: From onset of evaluation to the outcomes at 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Aug 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in